bmcneurol.biomedcentral.com

BMC Neurology

  • ️AlSafadi, Ammar M.
  • ️Tue Apr 04 2017

Skip to main content

Peer Review reports

From: Bapineuzumab for mild to moderate Alzheimer’s disease: a meta-analysis of randomized controlled trials

Original Submission
17 Oct 2016 Submitted Original manuscript
3 Nov 2016 Reviewed Reviewer Report - Marwan Sabbagh
22 Nov 2016 Author responded Author comments - Abdelrahman Abushouk
Resubmission - Version 2
22 Nov 2016 Submitted Manuscript version 2
15 Jan 2017 Reviewed Reviewer Report - JOSHUA D. GRILL
7 Feb 2017 Author responded Author comments - Abdelrahman Abushouk
Resubmission - Version 3
7 Feb 2017 Submitted Manuscript version 3
15 Mar 2017 Reviewed Reviewer Report - JOSHUA D. GRILL
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
28 Mar 2017 Editorially accepted
4 Apr 2017 Article published 10.1186/s12883-017-0850-1

You can find further information about peer review here.

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us